Generic Name : Asparaginase Pronunciation : a spare' a gi nase
Therapeutic Classification : Chemotherapy Trade Name(s):
India- Asginase Vial, Celginase Inj, L-Aspase Vial, Leucoginase Vial, Leunase Vial, Oncoginase Vial, Onconase Vial.
International- Elspar. Why it is prescribed (Indications) : This medication is an antineoplastic agent, prescribed for lymphocytic leukemia either alone or with other medications. It stops cancer cell growth. When it is not to be taken (Contraindications): Contraindicated in patients with inflammation of pancreas and bleeding due to prior therapy with this medication and hypersensitivity.
Dosage & When it is to be taken : The recommended dose of elspar is 6, 000 International Units/m˛ intramuscularly (IM) or intravenously (IV) three times a week. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein or into the large muscle. Warnings and Precautions :
* Caution should be exercised in patients with history of liver, kidney or pancreatic disease, any allergy, who are taking other medications, elderly, during pregnancy and breast-feeding.
* It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
* It may reduce platelet counts, avoid injury or bruising.
* Avoid any vaccination during the treatment period.
Side Effects :
Nausea and vomiting, loss of appetite, depression, tiredness, confusion, restlessness or agitation and headache.
* Monitor complete blood counts, uric acid level and blood glucose level regularly while taking this medication. * Avoid using contaminated solution of this medication.
* Avoid excess dosage. Storage Conditions :
Normally handled and stored by healthcare providers.
Comment & Contribute
Ask an Expert